Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC.

Giulia Pasello,Alessandro Dal Maso,Martina Lorenzi,Elisa Roca,Sara Pilotto,Marianna Macerelli,Valentina Polo,Alessandro Del Conte,Giorgia Nardo,Vanessa Buoro,Daniela Scattolin,Sara Monteverdi,Loredana Urso,Elisabetta Zulato,Stefano Frega,Laura Bonanno,Stefano Indraccolo,Fiorella Calabrese,Pierfranco Conte

Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC.

2019

Giulia Pasello
Alessandro Dal Maso
Martina Lorenzi
Elisa Roca
Sara Pilotto
Marianna Macerelli
Valentina Polo
Alessandro Del Conte
Giorgia Nardo
Vanessa Buoro
Daniela Scattolin
Sara Monteverdi
Loredana Urso
Elisabetta Zulato
Stefano Frega
Laura Bonanno
Stefano Indraccolo
Fiorella Calabrese
Pierfranco Conte

e20612Background: Acquired T790M EGFR mutation (mut) is not predictable by any clinical-pathological feature. The best time point for T790M mut detection by liquid or tissue biopsy is currently und...

Keywords:

T790M
Cancer research
Mutant
Pathology
Medicine
tissue biopsy
egfr mutation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations